603 filings
Page 8 of 31
8-K
vhfv2f3j
22 Jul 19
Departure of Directors or Certain Officers
4:05pm
8-K
wyw z558eslmr
17 Jun 19
Protalix BioTherapeutics Completes Enrollment in the Phase III BRIGHT Clinical Trial of
7:08am
8-K
0lwdkrxltby8a
6 Jun 19
BLA Submission Expected First Quarter 2020
7:09am
8-K
7rcj1u7ms9d1xe 2s
31 May 19
Submission of Matters to a Vote of Security Holders
7:00am
8-K
j2ojxan8zt3
21 May 19
Protalix BioTherapeutics Appoints Dror Bashan as its New President and Chief Executive Officer and Director
7:35am
8-K
rma78mstz
6 May 19
Protalix BioTherapeutics Reports 2019 First Quarter Results and Provides Corporate Update
7:08am
EFFECT
lkvnw425xie61vey
15 Apr 19
Notice of effectiveness
12:16am
CORRESP
2a53z2d4
10 Apr 19
Correspondence with SEC
12:00am
UPLOAD
r3ny2l5ysucig uq5lrj
8 Apr 19
Letter from SEC
12:00am
8-K
dq6ug7le8lsnbi650
18 Mar 19
Protalix BioTherapeutics Reports 2018 Full Year Results and Provides Corporate Update
6:59am
UPLOAD
tbiqg bbqpco
15 Mar 19
Letter from SEC
12:00am
CORRESP
kcyltor2bx83a5dc2e68
11 Mar 19
Correspondence with SEC
12:00am
UPLOAD
zyi2a199dte sx
14 Feb 19
Letter from SEC
12:00am